2m 2m 2m 2m 2m 2m 2m
MAZE THERA (MAZE)
NASDAQ
$26.41+$0.84 (+3.29%)
Price as of Jun 23, 2026 5:13 PM EDT- $1.4BMarket Cap
- 138.30%1-Year Change
- BiotechnologyIndustry
MAZE THERA (MAZE)
$26.41+$0.84 (+3.29%)
Annual
Quarterly
12/31/2025 | ||
|---|---|---|
Income Statement | ||
Total Operating Revenue | 0 N/A | |
Cost of Revenue | N/A N/A | |
Gross Profit | 0 N/A | |
Sales and Marketing Expense | N/A N/A | |
Research and Development Expense | -108.4M N/A | |
Depreciation and Amortization Expense | 2.4M N/A | |
Total Operating Expenses | 142.9M N/A | |
Operating Profit | -142.9M N/A | |
Interest Income | 11.8M N/A | |
Interest Expense | N/A N/A | |
Interest Income and Expense and Net | 11.8M N/A | |
Total Nonoperating Income and Expense | N/A N/A | |
Income before Taxes | -131.1M N/A | |
Income Taxes | 0 N/A | |
Extraordinary Items | N/A N/A | |
Net Income | -131.1M N/A | |
Net Income from Continuing Operations Applicable to Common | -131.1M N/A | |
Basic EPS and Net Income | -3.05 N/A | |
Diluted EPS and Net Income | -3.05 N/A | |
Basic Weighted Average Shares | 43.0M N/A | |
Diluted Weighted Average Shares | 43.0M N/A | |
Balance Sheet | ||
Cash and Cash Equivalents | 189.2M N/A | |
Short-Term Investments | 152.7M N/A | |
Cash and Cash Equivalents and Short-Term Investments | 341.9M N/A | |
Total Current Assets | 349.7M N/A | |
Accumulated Depreciation | 19.2M N/A | |
Property and Plant and Equipment and Net | 5.0M N/A | |
Total Long-Term Assets | 3.0M N/A | |
Total Assets | 397.1M N/A | |
Income Taxes Payable | N/A N/A | |
Total Short-Term Debt | N/A N/A | |
Total Current Liabilities | 22.6M N/A | |
Total Long-Term Debt | 0 N/A | |
Total Long-Term Liabilities | 1.1M N/A | |
Total Liabilities | 42.2M N/A | |
Retained Earnings | -489.5M N/A | |
Total Stockholders Equity | 355.0M N/A | |
Total Shares Outstanding | 49.3M N/A | |
Cash Flow | ||
Cash from Operating Activities | -111.9M N/A | |
Capital Expenditures | 794,000 N/A | |
Cash from Investing Activities | -171.0M N/A | |
Dividends Paid | N/A N/A | |
Cash from Financing Activities | 275.3M N/A | |
Financials Ratio | ||
Gross Margin | N/A N/A | |
Operating Margin | N/A N/A | |
Return on Assets | N/A N/A | |
Return on Equity | N/A N/A | |
Revenue Growth | N/A N/A | |
Current Ratio | N/A N/A | |
Cash Ratio | N/A N/A | |
Debt-to-Equity Ratio | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow